One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial

PURPOSE: Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) is a standard of care for medically inoperable patients. Our aim was to compare Common Terminology Criteria for Adverse Events (CTCAE) thoracic grade 3 or higher adverse events (AEs) of 30 Gy in on...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Radiat Oncol Biol Phys
Asıl Yazarlar: Singh, Anurag K., Gomez-Suescun, Jorge A., Stephans, Kevin L., Bogart, Jeffrey A., Hermann, Gregory M., Tian, Lili, Groman, Adrienne, Videtic, Gregory M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043929/
https://ncbi.nlm.nih.gov/pubmed/31445956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.08.019
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller